PARIS, April 5, 2006 – In this first study of its kind in men with erectile dysfunction who had not previously been treated with a phosphodiesterase type 5 (PDE5) inhibitor, 81% of men who took Levitra (vardenafil) reported improved erections (81% with Levitra vs 30% who took a placebo; p<0.0001). 78% of men were able […]
NEW YORK - In a sign of how Pfizer Inc. hopes to boost the market for erectile dysfunction drugs, the maker of impotency pill Viagra plans to launch a second non-branded, educational ad campaign about the condition on Wednesday to complement one running since late last year.
The double-dose of education comes as Pfizer tries to […]
Dear Dr. Donohue: Will you please address the issue of Viagra causing blindness? How risky is it to use Viagra? Should a man (a friend) take it if he has very little vision in one eye? I am very concerned.
— T.Y.
http://www.drugonline.cc
A: When the announcement was made about Viagra causing vision loss, many men were very […]
The Philadelphia region’s largest insurer says it will make 22 changes to its preferred list of pharmaceuticals for Medicare recipients starting June 1, marking the beginning of a shift that could alter drug plans across the country.
The changes by Independence Blue Cross appear mild and affect only a small fraction of the 3,000 drugs on […]
PARIS (Reuters Health) - Levitra not only enables men with erectile dysfunction (ED) to engage successfully in sexual intercourse, it also significantly improves partner satisfaction. http://www.drugonline.cc
ADVERTISEMENT
“I think that over the years, trials of erectile dysfunction have not attributed enough consideration to the couple component. Our new trial shows that successful therapy for erectile dysfunction with […]
Japan - the second largest single-country pharmaceutical market in the world - represents a very large and relatively untapped erectile dysfunction (ED) therapeutic market. After providing an overview of the ED landscape in Japan, this report examines why promotional campaigns for the ED drugs available in Japan have failed to generate the level of sales […]